Skip to content
OpenCapital
Get started

Aemetis, Inc. AMTX Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Segments

By segment

See full
India Biodiesel42%—

Other financials

Income statement

See full
Revenue$54.6M+27.4%
Gross profit$2.8M+154%
Operating income-$6.3M+59.3%
Net income-$21.7M+11.5%
EPS (diluted)-$0.33+29.8%

Balance sheet

See full
Cash & equivalents$4.8M+861%
Total debt$101.8M+18.6%
Total equity-$321.1M-14.4%
Total assets$270.3M+4.0%

Cash flow

See full
Operating cash flow-$10.6M-6,698%
CapEx$6.5M+259%
Free cash flow-$17.1M-927%

Valuation

See full
Market cap$116.1M-12.6%
Enterprise value$213.07M-0.6%
P/S0.6×0.0×

Profitability

See full
Gross margin-1.6%-0.3pp
Operating margin-13.4%-3.2pp
Net margin-35.4%-1.4pp
FCF margin-18.2%+1.1pp

Returns & leverage

See full
Return on equity24.7%—
Debt / equity-0.3×—
Current ratio0.1×-0.1×